Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Merck & Company (MRK)

Merck & Company (MRK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 208,443,264
  • Shares Outstanding, K 2,574,645
  • Annual Sales, $ 42,294 M
  • Annual Income, $ 6,220 M
  • 60-Month Beta 0.57
  • Price/Sales 4.85
  • Price/Cash Flow 12.85
  • Price/Book 7.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 1.16
  • Number of Estimates 4
  • High Estimate 1.19
  • Low Estimate 1.13
  • Prior Year 1.06
  • Growth Rate Est. (year over year) +9.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.63 +3.06%
on 07/12/19
87.07 -6.93%
on 07/03/19
-1.74 (-2.10%)
since 06/14/19
3-Month
72.23 +12.20%
on 04/18/19
87.07 -6.93%
on 07/03/19
+3.48 (+4.49%)
since 04/16/19
52-Week
62.01 +30.70%
on 07/20/18
87.07 -6.93%
on 07/03/19
+18.45 (+29.48%)
since 07/16/18

Most Recent Stories

More News
Glaxo's Zejula Meets Goal in First-Line Ovarian Cancer Study

Glaxo's (GSK) phase III study evaluating Zejula as a first-line maintenance therapy in patients with ovarian cancer meets the primary endpoint.

MRK : 81.35 (+0.48%)
CLVS : 12.85 (-0.85%)
RHHBY : 33.6200 (+0.21%)
GSK : 41.21 (+0.76%)
The Zacks Analyst Blog Highlights: Cisco, Home Depot, Merck, Humana and Public Service Enterprise

The Zacks Analyst Blog Highlights: Cisco, Home Depot, Merck, Humana and Public Service Enterprise

HUM : 286.85 (+0.54%)
PEG : 60.64 (-0.67%)
CSCO : 57.90 (-0.26%)
MRK : 81.35 (+0.48%)
HD : 217.51 (-0.54%)
Blue Prism Drives Innovation and Modernization Across Pharmaceutical and Life Sciences Industries

Leading companies in the life sciences and pharmaceutical industries such as Celgene, Merck KGaA, Pfizer, and Pharmaceutical Product Development (PPD) are turning to Blue Prism (AIM: PRSM), a global leader...

MRK : 81.35 (+0.48%)
MKKGY : 20.7300 (+0.10%)
J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View

J&J (JNJ) beats estimates for both earnings and sales in the second quarter of 2019 and raises 2019 guidance for operational sales growth for the second time this year.

MRK : 81.35 (+0.48%)
JNJ : 132.97 (-1.29%)
ABBV : 69.54 (-1.04%)
TEVA : 8.40 (-1.87%)
Thinking about trading options or stock in AMD, Alibaba, Merck, Roku, or Tesla?

InvestorsObserver issues critical PriceWatch Alerts for AMD, BABA, MRK, ROKU, and TSLA.

BABA : 174.24 (+0.43%)
TSLA : 252.08 (-0.56%)
MRK : 81.35 (+0.48%)
Merck's Embracing Carers(TM) Launches 'Time Counts' to Raise 1 Million Minutes of Support for Carers

- 'Time Counts' launches as a social media-led video series asking the global community to collectively give 1 million minutes to better support carers

MRK : 81.35 (+0.48%)
Top Stock Reports for Cisco, Home Depot & Merck

Top Stock Reports for Cisco, Home Depot & Merck

HUM : 286.85 (+0.54%)
PEG : 60.64 (-0.67%)
CSCO : 57.90 (-0.26%)
AZN : 40.20 (-0.05%)
MRK : 81.35 (+0.48%)
HD : 217.51 (-0.54%)
Merck & Co (MRK) Approaches New Upside Target of $82.02

Shares of Merck & Co (NYSE:MRK) have bullishly opened above the pivot of $79.75 today and have reached the first resistance level of $80.88. Investors may be interested in a cross of the next upside pivot...

MRK : 81.35 (+0.48%)
J&J Falls Amid Reports of Criminal Probe Into Talcum Powder

The U.S. Justice Department is reportedly pursuing a criminal investigation as to whether J&J (JNJ) lied about the possible cancer risk associated with its talcum powder.

MRK : 81.35 (+0.48%)
JNJ : 132.97 (-1.29%)
NVS : 89.11 (-0.18%)
RHHBY : 33.6200 (+0.21%)
Kinnevik agrees to purchase Livongo shares

Kinnevik AB (publ) ("Kinnevik") today announced that it has agreed to purchase shares of Livongo Health, Inc. ("Livongo") from Merck Global Health Innovation Fund, LLC ("Merck") at a price per share equal...

MRK : 81.35 (+0.48%)
KNVKF : 26.0908 (+0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade MRK with:

Business Summary

Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies...

See More

Key Turning Points

2nd Resistance Point 81.93
1st Resistance Point 81.45
Last Price 81.35
1st Support Level 80.30
2nd Support Level 79.63

See More

52-Week High 87.07
Last Price 81.35
Fibonacci 61.8% 77.50
Fibonacci 50% 74.54
Fibonacci 38.2% 71.58
52-Week Low 62.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar